Using Quantitative Systems Pharmacology Modeling to Optimize Combination Therapy of Anti-Pd-l1 Checkpoint Inhibitor and T Cell Engager
FRONTIERS IN PHARMACOLOGY（2023）
Key words
immune-oncology,quantitative systems pharmacology (QSP),immune checkpoint inhibitor,bispecific T cell engager,virtual clinical trial,dose optimization
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined